Novo Nordisk



For 95 years, Novo Nordisk, a global leader in diabetes care, has been committed to discovering and developing innovative medicines to help people with chronic diseases lead longer, healthier lives.
 

Featured Products

  

Literature 

Ozempic and cardiovascular outcomes in patients with type 2 diabetes
Ozempic versus Trulicity once weekly in patients with type 2 diabetes: a randomized, open-label phase 3b trial 
 


 

Novo Nordisk
Contact Information 
Melissa Harakuni
323.243.0424
mlhz@novonordisk.com
novonordisk.us